NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/26/2023
Back to search
Official data from USPTO
COGENTECH MEDICAL & DIGITAL INNOVATION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
09/26/2023
Classification
Registered
Trademark type
Combined
Nice classes
35, 42
Filing date
09/02/2021
Registration date
09/26/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/26/2023
Last transaction
09/26/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
12/18/2020
First use in commerce
12/18/2020
Drawing code
3
Owner type
03
Owner location
Mahwah, NJ, US
Examiner
CHOSID, ROBIN S
Law office
O30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "CogenTech" in stylized font with the Cogent icon as the "o". The "C" and the "T" are capital letters. Situated under bottom right to the "g" is the phrase,"Medical & Digital Innovation". This slogan is justified to the right.
Holders and representatives
Holders
C. C. (pessoa física)
Representatives
Todd A. Denys Porzio, Bromberg & Newman, P.C.
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medical devicebiopharmaceuticalbiotechnology companies to assist them with clinical researchclinical trialsapplications for drug approval using medical technology and software products
Class 42
Clinical research in the field of medical devices; Scientific research in the nature of conducting clinical trials for others; Scientific research in the nature of conducting clinical trials for others in the field of medical devices and biopharmaceutical companies; Consulting services for others in the field of designplanningimplementation project management of global clinical trials and regulatory process for lifesciences companiesacademic institutionsincluding data analytics therefor; Providing information in the field of clinical research via a website
Publications
History of USPTO decisions and trademark events.
32 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/26/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/11/2023
PUBO
PUBLISHED FOR OPPOSITION
07/11/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/21/2023
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/06/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/30/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
05/30/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/30/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
05/30/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/30/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/20/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/19/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/19/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/20/2022
GNRT
NON-FINAL ACTION E-MAILED
09/20/2022
CNRT
NON-FINAL ACTION WRITTEN
09/20/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
09/20/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/20/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
09/20/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/20/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/15/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/15/2022
ALIE
ASSIGNED TO LIE
09/15/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/11/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/27/2022
GNRT
NON-FINAL ACTION E-MAILED
06/27/2022
CNRT
NON-FINAL ACTION WRITTEN
06/27/2022
DOCK
ASSIGNED TO EXAMINER
06/07/2022
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/16/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/15/2021
NWAP
NEW APPLICATION ENTERED
09/06/2021
Continuous trademark protection
Get notified about every new filing that threatens COGENTECH MEDICAL & DIGITAL INNOVATION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.